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The engineering of synthetic metabolic pathways in microbial hosts holds much 
promise for the synthesis of new chemicals and materials, including a variety of natural 
and non-natural products. The benzylisoquinoline alkaloids (BIAs) represent a large and 
structurally diverse class of plant secondary metabolites that exhibit a broad range of 
pharmacological activities. The reconstitution of a BIA biosynthetic pathway in an 
engineered microbial host offers several advantages over isolation from plants, including 
the targeted production of key intermediate molecules, rapid biomass accumulation, ease 
of purification, and the availability of genetic tools for strain engineering and pathway 
optimization.  
Here we describe the development of a synthetic BIA pathway in an engineered 
yeast host which incorporates heterologous enzymes from a variety of organisms. The 
BIA backbone is derived from two molecules of tyrosine and is assembled through a 
heterologous pathway comprising enzymatic activities from plants, bacteria, and humans. 
Simultaneous efforts have focused on the downstream portion of this pathway to convert 
a commercially available substrate to the major branch point intermediate reticuline. By 
synthesizing both stereoisomers of reticuline from a racemic substrate, we have 
demonstrated production of BIA metabolites along the diversified sanguinarine/berberine 
and morphinan branches. Further optimization, scale-up, and a combination of 
bioconversions and chemical synthesis will potentially revolutionize drug discovery and 
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